Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GILEAD SCIENCES, INC. Director's Dealing 2026

Mar 17, 2026

29828_dirs_2026-03-17_32cc44e5-c518-49a2-84c3-a44d1fb9e480.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES, INC. (GILD)
CIK: 0000882095
Period of Report: 2026-03-16

Reporting Person: Dickinson Andrew D (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-03-16 Common Stock S 3000 $144.23 Disposed 179191 Direct

Footnotes

F1: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.